secwatch / observer
8-K filed March 30, 2023, 7:59 PM ET ticker KLNG CIK 0001110607
earnings confidence high sentiment negative materiality 0.70

Koil Energy reports FY2022 net loss of $2.9M; revenue down 25% to $13.0M

Koil Energy Solutions, Inc.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Koil Energy Solutions, Inc. reported three months ended December 31, 2022 results: revenue $3.6 million, net income $1.3 million, EPS $0.11 loss per diluted share.

Period
three months ended December 31, 2022
Revenue
$3.6 million
Net income
$1.3 million
EPS
$0.11 loss per diluted share
Result
reported results
Exact text from the filing
Koil Energy’s revenues for the three months ended December 31, 2022 (“Q4 2022”) decreased 31 percent to $3.6 million compared to $5.2 million for the three months ended December 31, 2021 (“Q4 2021”).
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Koil Energy Solutions, Inc. reported year ended December 31, 2022 results: revenue $13.0 million, net income $2.9 million, EPS $0.24 loss per diluted share.

Period
year ended December 31, 2022
Revenue
$13.0 million
Net income
$2.9 million
EPS
$0.24 loss per diluted share
Result
reported results
Exact text from the filing
decreased 31 percent to $3.6 million compared to $5.2 million for the three months ended December 31, 2021 (“Q4 2021”). Our full-year 2022 revenues decreased 25 percent to $13.0 million, compared with $17.2 million for full-year 2021, primarily due to an overall decline in project activity characterized by a shift from product-oriented, fixed price contracts to
View on SEC.gov

Browse all earnings releases →

Koil Energy Solutions, Inc. filing history →

Source: SEC EDGAR
accession 0001683168-23-001977
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.